Therapeutic options for refractory gastroesophageal reflux disease
Author:
- 4 April 2012
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27 (s3) , 3-7
Abstract
Refractory gastroesophageal reflux disease may affect up to one-third of the patients that consume proton pump inhibitor (PPI) once daily. Treatment in clinical practice has been primarily focused on doubling the PPI dose, despite lack of evidence of its value. In patients who failed PPI twice daily, medical treatment has been primarily focused on reducing transient lower esophageal sphincter relaxation rate or attenuating esophageal pain perception using visceral analgesics. In patients with evidence of reflux as the direct trigger of their symptoms, endoscopic treatment or antireflux surgery may be helpful in remitting symptoms. The role of psychological interventions, as well as non-traditional therapeutic strategies remains to be further elucidated.Keywords
This publication has 53 references indexed in Scilit:
- Reflux Parameters as Modified by Laparoscopic Fundoplication in 40 Patients with Heartburn/Regurgitation Persisting Despite PPI Therapy: A Study Using Impedance-pH MonitoringDigestive Diseases and Sciences, 2010
- Nonerosive Reflux Disease (NERD) - An UpdateJournal of Neurogastroenterology and Motility, 2010
- A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux diseaseGut, 2009
- Antireflux Transoral Incisionless Fundoplication Using EsophyX: 12‐Month Results of a Prospective Multicenter StudyWorld Journal of Surgery, 2008
- Pyloric Injection of Botulinum Toxin for the Treatment of Refractory GERD Accompanied with Gastroparesis: A Preliminary ReportDigestive Diseases and Sciences, 2008
- The influence of co‐morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2008
- Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: A randomized controlled trialThe Journal of Pediatrics, 2006
- Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapyDiseases of the Esophagus, 2005
- Antidepressant Treatment of Patients with Diffuse Esophageal SpasmJournal of Clinical Gastroenterology, 1999
- Symptomatic gastroesophageal reflux: Incidence and precipitating factorsDigestive Diseases and Sciences, 1976